tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PROK Stock Latest News

ProKidney’s Progress in FDA Approval and Financial Health
Company AnnouncementsProKidney’s Progress in FDA Approval and Financial Health
9d ago
PROK
ProKidney reports Q3 EPS (14c), consensus (15c)
PremiumThe Fly
ProKidney reports Q3 EPS (14c), consensus (15c)
9d ago
PROK
PROK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PROK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11d ago
PROK
ProKidney initiated with a Neutral at JPMorgan
PremiumThe Fly
ProKidney initiated with a Neutral at JPMorgan
2M ago
PROK
ProKidney initiated with a Buy at Guggenheim
PremiumThe Fly
ProKidney initiated with a Buy at Guggenheim
2M ago
PROK
ProKidney price target lowered to $3 from $4 at BofA
PremiumThe FlyProKidney price target lowered to $3 from $4 at BofA
3M ago
PROK
ProKidney: Investor Update and Phase 3 Program Progress
Premium
Company Announcements
ProKidney: Investor Update and Phase 3 Program Progress
3M ago
8K
PROK
ProKidney to discontinue PROACT 2, focus resources on PROACT 1
Premium
The Fly
ProKidney to discontinue PROACT 2, focus resources on PROACT 1
3M ago
PROK
ProKidney sees cash runway into mid-2026
PremiumThe Fly
ProKidney sees cash runway into mid-2026
3M ago
PROK
ProKidney reports Q2 EPS (16c), consensus (17c)
PremiumThe Fly
ProKidney reports Q2 EPS (16c), consensus (17c)
3M ago
PROK
Short Report: Sirius XM bears pressing bets into stock rally
PremiumThe Fly
Short Report: Sirius XM bears pressing bets into stock rally
5M ago
ALT
KSS
ProKidney 53.72M share Secondary priced at $2.42
PremiumThe Fly
ProKidney 53.72M share Secondary priced at $2.42
5M ago
PROK
ProKidney announces $125M Class A ordinary shares offering
PremiumThe FlyProKidney announces $125M Class A ordinary shares offering
5M ago
PROK
ProKidney price target lowered to $6 from $15 at Jefferies
Premium
The Fly
ProKidney price target lowered to $6 from $15 at Jefferies
5M ago
PROK
ProKidney Progresses in Kidney Disease Treatment Trials and Regulation
Premium
Company Announcements
ProKidney Progresses in Kidney Disease Treatment Trials and Regulation
5M ago
8K
PROK
ProKidney announces ‘positive’ interim REGEN-007 Phase 2 trial data
PremiumThe Fly
ProKidney announces ‘positive’ interim REGEN-007 Phase 2 trial data
5M ago
PROK
ProKidney Phase 2 Trial Success Sparks Investor Interest
PremiumCompany Announcements
ProKidney Phase 2 Trial Success Sparks Investor Interest
6M ago
8K
PROK
ProKidney price target raised to $4 from $3 at BofA
PremiumThe Fly
ProKidney price target raised to $4 from $3 at BofA
6M ago
NVO
PROK
ProKidney sees cash runway into 4Q25
PremiumThe Fly
ProKidney sees cash runway into 4Q25
7M ago
PROK
ProKidney reports Q1 EPS (16c) vs. (16c) last year
PremiumThe FlyProKidney reports Q1 EPS (16c) vs. (16c) last year
7M ago
PROK
ProKidney Bolsters Leadership with Expert EVP, Enhances Operations
Premium
Company Announcements
ProKidney Bolsters Leadership with Expert EVP, Enhances Operations
8M ago
8K
PROK
ProKidney appoints Ulrich Ernst as EVP, technical operations
Premium
The Fly
ProKidney appoints Ulrich Ernst as EVP, technical operations
8M ago
PROK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >